Crossref
Anticoagulant therapy in patients with atypical COVID-19 pneumonia
Journal of Life Science and Biomedicine · 2021
DOI: 10.51145/jlsb.2021.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Life Science and Biomedicine, 2021. Verfasst von Ravshan Aliyevich IBADOV und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
IBADOV, R. A., KHAMRAEVA, G. S., & IBRAGIMOV, S. K. (2021). Anticoagulant therapy in patients with atypical COVID-19 pneumonia. Journal of Life Science and Biomedicine. https://doi.org/10.51145/jlsb.2021.5
Vancouver
IBADOV RA, KHAMRAEVA GS, IBRAGIMOV SK. Anticoagulant therapy in patients with atypical COVID-19 pneumonia. Journal of Life Science and Biomedicine. 2021. doi:10.51145/jlsb.2021.5
BibTeX
@article{IBADOV2021,
author = {IBADOV, Ravshan Aliyevich and KHAMRAEVA, Gulchekhra Shakhobovna and IBRAGIMOV, Sardor Khamdamovich},
title = {Anticoagulant therapy in patients with atypical COVID-19 pneumonia},
journal = {Journal of Life Science and Biomedicine},
year = {2021},
doi = {10.51145/jlsb.2021.5}
}
EUVIMED